Following the receipt of KES 446 million NIHR Oesophageal Cancer Research Grant, KUTRRH alongside our University of Manchester colleagues commenced the project activities in August 2022.
The second of its kind in Africa after Egypt. KUTRRH Cyberknife is set to revolutionize cancer treatment not only in Kenya but also in the region.
KUTRRH achieved another significant milestone with the launch of the formulary list by the KUTRRH CEO, Mr. Ahmed Dagane, on 3rd Aug 2022.
KUTRRH’s Dr. George Njoroge discovered Hepatitis C Treatment known as VictrelisTM on May 13, 2011, and was approved by the FDA.
First Ear Surgery At KUTRRH. We witnessed the first head and neck multidisciplinary surgery case. The patient had Basal Cell carcinoma of the ear canal